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Introduction
Leishmaniasis is a major health problem that affects more than 
12 million people worldwide and is caused by over 20 different 
Leishmania species parasites that are endemic in tropical and sub-
tropical regions of Asia, the Middle East, sub-Saharan Africa, and 
South America (1, 2). Cutaneous leishmaniasis comprises up to 
half of Leishmania species infections, representing 0.7–1.2 million 
new cases each year (2). The cutaneous disease is routinely asso-
ciated with local inflammatory pathology that can occasionally 
spread to other sites to cause mucocutaneous and visceral leish-
maniasis. Despite being the second highest cause of mortality and 
the fourth leading cause of morbidity among tropical diseases, lit-
tle is known about the immunobiology of leishmaniasis (3).
Infection with Leishmania major (L. major) causes cutaneous 
leishmaniasis in humans and susceptible BALB/c mice. In the first 
hours after infection, resident macrophages, DCs, and neutrophils 
that are recruited to the infection site phagocytize Leishmania para-
sites and produce inflammatory mediators to contain the infection 
(4). However, these phagocytes also serve as obligate reservoirs for 
Leishmania replication (4). During chronic infection, T cell–medi-
ated adaptive immunity is critical for controlling and clearing Leish-
mania. Indeed, L. major infection was the first infectious mouse 
model that established the importance of Th1 versus Th2 balance in 
determining disease outcome (5, 6). Th1 responses associated with 
the production of IFN-γ, IL-12, and TNF-α were associated with 
resistance, better prognosis, and parasite clearance. In contrast, Th2-
adaptive immunity mediated by IL-4–, IL-5–, and IL-13–producing 
T cells increased disease susceptibility and persistence (5–7).
The innate immune system utilizes different sets of germ-
line-encoded receptors to detect L. major infections. These 
include TLR family members that are expressed at the plasma 
membrane and in endosomal compartments and several intra-
cellular receptors that are exclusively present in the cytoplasm (8, 
9). The intracellular Nod-like receptor (NLR) family comprises 
34 family members that sense pathogen- and danger-associated 
molecular patterns (PAMPs and DAMPs, respectively) in the cyto-
plasm (10, 11). A subset of these NLRs assembles inflammasomes, 
which are large multiprotein complexes that promote activation of 
inflammatory caspase 1. Active caspase 1 promotes the conversion 
of pro–IL-1β and pro–IL-18 into bioactive IL-1β and IL-18 (12). The 
NLRP3 inflammasome represents the best-characterized inflam-
masome, and it is minimally composed of the NLR protein NLRP3, 
the bipartite adaptor protein ASC, and caspase 1 (12–14). This 
inflammasome is activated in response to a variety of stimuli rang-
ing from bacterial toxins, bacterial RNA, ATP, nigericin, uric acid, 
and silica crystals (15). The NLRP3 inflammasome has emerged 
as an essential component of the host’s immune response against 
bacterial and viral pathogens (16–18), but its role during infection 
with protozoan parasites such as L. major is relatively unknown. 
Here, we show that the NLRP3 inflammasome is activated when 
susceptible BALB/c mice are infected with L. major and that the 
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zoan parasites remains poorly characterized. We infected BALB/c 
bone marrow–derived macrophages (BMDMs) with L. major to 
determine whether this promoted inflammasome-dependent 
cytokine secretion. We observed a dose-dependent increase in 
IL-1β and IL-18 release from infected BMDMs (Figure 1, A and B). To 
formally establish that IL-1β and IL-18 release was inflammasome 
dependent, we infected WT and Nlrp3–/–, Asc–/–, and Casp1–/–  
Casp11–/– BMDMs with L. major. Notably, L. major–induced IL-1β 
and IL-18 secretion was markedly diminished in Nlrp3–/–, Asc–/–, and 
Casp1–/– Casp11–/– BMDMs (Figure 1, C and D). The role of inflam-
masome signaling in mediating secretion of IL-1β and IL-18 was 
specific, because extracellular levels of the inflammasome-inde-
pendent cytokines IL-6, KC, and TNF-α were similar between 
L. major–infected WT and inflammasome-deficient BMDMs (Sup-
plemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI79526DS1). Moreover, L. major uptake 
by WT and Asc–/– BMDMs was comparable (Figure 1E and Sup-
plemental Figure 2), ruling out the possibility that reduced IL-1β 
of IL-1β and IL-18 in vitro and in vivo. Remarkably, we found that 
IL-18 enhanced IL-4 secretion by increasing GATA3 and cMAF 
expression in activated T cells, thereby skewing adaptive immu-
nity toward detrimental Th2 responses. Indeed, BALB/c mice 
lacking NLRP3, ASC, or caspase 1 produced less IL-18 and IL-4, 
which resulted in increased protection against leishmaniasis. In 
agreement, IL-18 neutralization protected susceptible BALB/c 
hosts against L. major infection. In conclusion, we demonstrate 
that NLRP3 inflammasome–induced bias of adaptive immunity 
toward Th2-type responses is detrimental during leishmaniasis.
Results
L. major induces inflammasome-dependent IL-1β and IL-18 secretion 
from infected macrophages. Inflammasomes promote the matura-
tion and release of IL-1β and IL-18 (19). Although inflammasome 
activation in response to bacteria, viruses, and fungal infection is a 
vital component of protective immunity (20), the role that inflam-
masomes play in regulating immune responses to unicellular proto-
Figure 1. L. major induces inflam-
masome-mediated IL-1β and IL-18 
production by macrophages in vitro. (A 
and B) BALB/c WT BMDMs were primed 
with 500 ng/ml LPS for 6 hours followed 
by the indicated MOI of L. major for 48 
hours. Supernatants from stimulated 
BMDMs were analyzed by ELISA for IL-1β 
(A) and IL-18 (B). (C and D) WT, Nlrp3–/–, 
Asc–/–, and Casp1–/– Casp11–/– BMDMs were 
stimulated with 500 ng/ml LPS for 6 
hours followed by L. major infection (20 
MOI) for 48 hours, and IL-1β (C) and IL-18 
(D) in the supernatants were examined 
by ELISA. (E) WT and Asc–/– BMDMs were 
infected with 20 MOI of L. major for  
1 hour. Infected BMDMs were washed to 
get rid of excess L. major and supple-
mented with fresh media. BMDMs were 
then immediately stained with Giemsa to 
determine phagocytosis of L. major  
(1 hour). Other groups of BMDMs were 
incubated for an additional 6 and 24 hours 
to determine clearance of phagocytosed 
L. major before Giemsa staining of the 
cells (6-hour and 24-hour time points). 
Giemsa-stained cells were examined 
under a light microscope to visualize 
L. major phagocytosis and clearance 
(original magnification, ×40). Data in A 
and B are the mean of duplicates and are 
representative of at least 3 independent 
experiments. Data in C and D are cumu-
lative of 3 to 5 independent experiments 
with n = 3–7 in each group. Images in 
E are representative of 3 independent 
experiments. The Mann-Whitney U test 
was performed to evaluate significant 
differences between WT and KO BMDMs. 
ELISA data are shown as the mean ± 
SEM. *P < 0.05; **P < 0.01.
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Figure 2. Inflammasome signaling promotes susceptibility to L. major infection in vivo. Footpads of WT (n = 28), Nlrp3–/– (n = 20), Asc–/– (n = 24), and 
Casp1–/– Casp11–/– (n = 18) mice were infected with 106 L. major promastigotes. (A) Footpad swelling was measured on days 21 and 28 after infection. (B) 
Representative images of footpads of WT BALB/c, Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice on day 28 after infection. (C) On day 28, mice were eutha-
nized, and L. major titers in the footpads of infected WT (n = 14), Nlrp3–/– (n = 10), Asc–/– (n = 12), and Casp1–/– Casp11–/– (n = 9) mice were determined using 
a limiting dilution assay as described in the Methods. (D) On day 28 after infection, footpad sections were stained with Giemsa to determine L. major 
titers. Red arrows indicate L. major amastigotes in the cytoplasm of cells in WT footpad sections (original magnification, ×60). (E) H&E-stained sections 
of the footpads from WT, BALB/c, Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice on day 28 after infection (original magnification, ×10). White asterisks in the 
H&E-stained section of the WT footpad show necrotic lesions in the inflamed footpad. Dunnett’s multiple comparisons test was performed to evaluate 
significance between multiple groups. Data represent the mean ± SEM. **P < 0.01; ***P < 0.001; ****P < 0.0001.
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genates of infected WT, Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice. 
L. major infection resulted in robust caspase 1 maturation in the 
footpads of infected WT mice. In contrast, the appearance of the 
caspase 1 p20 subunit was abrogated in homogenates of Nlrp3–/– 
and Asc–/– footpad samples (Figure 3A). As expected, immunore-
active bands were not detected in the homogenates of infected 
Casp1–/– Casp11–/– mice, demonstrating specificity of these results 
(Figure 3A). In agreement, we detected high levels of IL-1β and 
IL-18 in the footpad homogenates of L. major–infected WT mice 
that were significantly blunted in the absence of NLRP3, ASC, 
and caspase 1 (Figure 3, B and C). These results demonstrate that 
L. major induces local NLRP3 inflammasome activation and IL-1β 
and IL-18 production in the footpads of infected mice.
Increased resistance to L. major infection in NLRP3 inflam-
masome–deficient mice is associated with reduced Th2 cytokines 
and increased Th1 cytokines. Based on our collective observa-
tions, we hypothesized that increased IL-1β and IL-18 produc-
tion in L. major –infected WT mice promoted disease patho-
genesis by skewing adaptive immunity against the parasite. 
BALB/c mice are known to mount Th2-dominated adaptive 
immune responses during L. major infection that are charac-
terized by significant secretion of IL-4, IL-5, and IL-13 (5, 6). 
These Th2 cytokines inhibit macrophage activation and dampen 
their ability to resolve L. major infection (21–23). To elucidate 
how NLRP3 inflammasome signaling influences susceptibil-
ity to L. major infection, we investigated local levels of these 
Th2 cytokines in the footpads of infected WT, Nlrp3–/–, Asc–/–, 
and Casp1–/– Casp11–/– mice. Notably, amounts of IL-4 and IL-5 
were significantly reduced in the footpads of Nlrp3–/–, Asc–/–, and 
Casp1–/– Casp11–/– mice relative to the levels detected in WT con-
trols (Figure 4, A and B). Recent studies have shown that IL-17 
promotes cutaneous leishmaniasis in susceptible BALB/c mice 
(24). Given that IL-1 promotes Th17 cell differentiation and 
IL-17 production (25), we analyzed IL-17 in the footpads of these 
mice. Compared with WT mice, IL-17 levels were significantly 
reduced in the footpads of L. major–infected Nlrp3–/–, Asc–/–, and 
Casp1–/– Casp11–/– mice (Supplemental Figure 3). Concurrently, 
we detected markedly increased levels of Th1-associated IFN-γ 
in the footpads of L. major–infected Nlrp3–/–, Asc–/–, and Casp1–/–  
Casp11–/– mice compared with those in WT controls (Figure 4C). 
In contrast, IL-10 levels were not differentially modulated in WT, 
Nlrp3–/–, Asc–/–, or Casp1–/– Casp11–/– mice (Figure 4D). Together, 
these results suggest that the NLRP3 inflammasome controls 
host susceptibility to cutaneous L. major infection by modulating 
the balance between Th1 and Th2 responses.
and IL-18 secretion was due to defective L. major phagocytosis and 
clearance. Collectively, these experiments demonstrate that L. major 
induces inflammasome-mediated IL-1β and IL-18 secretion.
NLRP3 inflammasome activation increases susceptibility to in 
vivo L. major infection. To address the role of inflammasome sig-
naling in cutaneous leishmaniasis, footpads of WT BALB/c mice 
and mice lacking the inflammasome molecules NLRP3, ASC, 
or caspases 1 and 11 were cutaneously infected with L. major. 
All animals developed footpad swelling, but this was markedly 
attenuated in Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice relative 
to that seen in WT controls (Figure 2, A and B). In agreement, we 
observed significantly reduced parasite burden in the footpads 
of Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice (Figure 2C), sug-
gesting that defective NLRP3 inflammasome activation results 
in improved parasite clearance. Indeed, Giemsa staining showed 
numerous amastigotes in the footpads of WT mice, but not in 
those of infected Nlrp3–/–, Asc–/–, or Casp1–/– Casp11–/– mice (Figure 
2D). H&E-stained footpad sections of infected WT mice showed 
large necrotic lesions that were virtually absent in the footpads 
of infected Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice (Figure 2E). 
Taken together, these results demonstrate that NLRP3 inflam-
masome activation contributes to host susceptibility during 
L. major infection in susceptible BALB/c mice.
NLRP3 mediates local caspase 1 activation and inflammasome- 
associated cytokine production at the site of infection. Having estab-
lished that defective NLRP3 inflammasome activation conferred 
protection against L. major pathogenesis (Figure 2), we sought to 
determine whether this resulted from local inflammasome activa-
tion in the footpads of cutaneously infected mice. To this end, we 
evaluated L. major–induced caspase 1 processing in footpad homo-
Figure 3. L. major induces NLRP3 inflammasome activation in vivo. WT 
(n = 14), Nlrp3–/– (n = 10), Asc–/– (n = 16), and Casp1–/– Casp11–/– (n = 9) mice 
were infected with 106 L. major promastigotes. Twenty-eight days later, 
the infected footpads were harvested and homogenized as detailed in 
the Methods. (A) Protein lysates from the representative footpads were 
run on an SDS-PAGE gel, and activation of caspase 1 was determined by 
Western blotting. GAPDH was used as a loading control. (B and C) IL-1β 
and IL-18 cytokine levels were determined by ELISA in the footpad lysates. 
Dunnett’s multiple comparisons test was performed to evaluate signifi-
cance between multiple groups. Data were combined from 2 independent 
experiments and represent the mean ± SEM. ***P < 0.001; ****P < 0.0001.
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the NLRP3 inflammasome in biasing adaptive immune responses 
toward a Th2 profile during L. major infection.
Inflammasome-mediated IL-18 production, rather than IL-1β, 
regulates Th2 responses. We showed that defective NLRP3 inflam-
masome–induced IL-1β and IL-18 production is associated with 
increased resistance to L. major infection. This was associated 
with reduced Th2 responses (IL-4 and IL-5 production) and a 
concomitant increase in Th1 responses (IFN-γ and TNF produc-
tion). To determine the relative contributions of IL-1β and IL-18 
to balancing Th1- and Th2-adaptive immunity, splenocytes from 
WT BALB/c mice were stimulated for 72 hours in vitro with anti-
CD3 monoclonal antibodies in the presence or absence of IL-1β 
and IL-18. Following stimulation, production of the hallmark 
Th1 (IFN-γ) and Th2 (IL-4) cytokines was analyzed in culture 
supernatants. As reported, IL-1β and IL-18 triggered T cells to 
produce IFN-γ, but not IL-4, in the absence of anti-CD3 stimula-
tion (Supplemental Figure 6). Interestingly, we found that IL-18 
significantly reduced the production of IFN-γ by anti-CD3–stim-
ulated splenocytes (Figure 6A). Furthermore, IL-18 significantly 
enhanced the ability of anti-CD3–stimulated splenocytes to 
produce IL-4 (Figure 6B). These IL-18–induced responses were 
specific, because IL-18–binding protein (IL-18BP) reduced IL-18–
dependent IL-4 production to the levels observed with anti-CD3 
stimulation alone (Figure 6C). Unlike IL-18, recombinant IL-1β 
did not significantly modulate IFN-γ and IL-4 production by anti-
CD3–activated T cells (Figure 6, A–C), nor did it act synergistically 
with IL-18 to dampen IFN-γ and increase IL-4 production (Supple-
mental Figure 6). These results demonstrate that IL-18 has a direct 
role in skewing the Th1 and Th2 profiles of activated T cells and 
suggest that NLRP3 inflammasome–driven IL-18 enhances IL-4 
production, which increases L. major pathogenesis. To directly 
analyze the importance of IL-18 in cutaneous leishmaniasis, IL-18 
was neutralized in infected mice by treating them with IL-18BP 
in vivo. Remarkably, footpad swelling and local L. major titers in 
the footpads and lymph nodes of infected BALB/c mice were sig-
nificantly reduced with IL-18BP treatment compared with PBS-
treated controls (Figure 6, D and E, and Supplemental Figure 7A). 
As expected, IL-4 levels in the footpads were significantly reduced 
in the IL-18BP–treated groups (Figure 6F).
To evaluate the mechanistic details of how IL-18 promotes 
IL-4 responses, we treated anti-CD3–stimulated splenocytes 
with IL-18 or IL-1β and measured the expression of the IL-4–pro-
moting transcription factors GATA3 and cMAF in CD4+ T cells 
(30, 31). IL-4 signaling is a known regulator of GATA3 expres-
sion (32, 33). As expected, the addition of IL-4 increased GATA3 
expression, while neutralization of IL-4 (anti–IL-4 mAb) reduced 
GATA3 expression on CD4+ T cells (Supplemental Figure 7B). 
NLRP3 inflammasome deficiency results in enhanced T cell–
mediated IFN-γ production during L. major infection. In addition 
to increasing Th2-associated cytokines, our results showed that 
the NLRP3 inflammasome dampens local IFN-γ production in the 
footpads of infected mice. IFN-γ is associated with resistance to 
L. major infection, and T cells have been identified as the major 
source of IFN-γ during L. major infection (6, 26). We therefore 
investigated whether increased IFN-γ levels in Nlrp3–/–, Asc–/–, 
and Casp1–/– Casp11–/– mice were associated with greater produc-
tion of IFN-γ by T cells. We detected similar frequencies of CD4+ 
and CD8+ T cells in the lymph nodes of WT, Nlrp3–/–, Asc–/–, and 
Casp1–/– Casp11–/– mice that were infected with L. major (Supple-
mental Figure 4). In contrast, the frequency of IFN-γ–producing 
CD4+ T cells was significantly increased in the absence of NLRP3, 
ASC, and caspase 1 (Figure 5, A and B). In addition, gated analy-
sis of CD4+IFN-γ+ T cells showed increased IFN-γ production by 
CD4+ T cells from Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– mice on 
a per-cell basis (Figure 5, C and D). Analysis of the CD8+ T cell 
population in the draining popliteal lymph nodes showed simi-
larly increased frequencies of IFN-γ–producing T cells in Nlrp3–/–, 
Asc–/–, and Casp1–/– Casp11–/– mice. Moreover, we also noted that 
these CD8+IFN-γ+ T cells produced greater amounts of IFN-γ on a 
per-cell basis (Figure 5, E–H).
TNF is another Th1 cytokine produced by activated T cells and 
confers protection against L. major infection (27–29). Notably, we 
observed significantly increased frequencies of TNF-α–producing 
CD4+ and CD8+ T cells in L. major–infected Nlrp3–/–, Asc–/–, and 
Casp1–/– Casp11–/– mice relative to those detected in BALB/c WT 
controls (Supplemental Figure 5), further supporting a key role for 
Figure 4. NLRP3 inflammasome signaling induces a Th2-biased cytokine 
profile in the footpads of L. major–infected mice.  (A–D) Supernatants 
from homogenized footpads of L. major–infected WT (n = 14), Nlrp3–/–  
(n = 10), Asc–/– (n = 16), and Casp1–/– Casp11–/– (n = 9) mice on day 28 after 
infection were analyzed by ELISA for the presence of IL-4 (A), IL-5 (B), 
IFN-γ (C), and IL-10 (D). Data were combined from 2 independent experi-
ments and represent the mean ± SEM. Significance was determined using 
Dunnett’s multiple comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001.
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In agreement with our previous data, IL-18, but not 
IL-1β, increased GATA3 expression on CD4+ T cells 
(Figure 6, G and H). Similar to GATA3, IL-18 increased 
the expression of cMAF in anti-CD3–stimulated 
CD4+ T cells (Supplemental Figure 7C). Collectively, 
our results establish IL-18 production by the NLRP3 
inflammasome as a central regulator of adaptive 
immunity that promotes Th2 responses and increases 
L. major pathogenesis in susceptible hosts (Figure 7).
Discussion
Leishmaniasis is an infectious disease caused by Leish-
mania species and represents a major health problem 
in equatorial developing countries. Visceral and cuta-
neous leishmaniasis are the 2 prevalent forms of the 
disease (34, 35). Despite substantial efforts, the immu-
nobiology of leishmaniasis is not well understood. 
Here, we made use of the cutaneous L. major infection 
model to study the role of inflammasome signaling in 
leishmaniasis (36). To this end, we backcrossed mice 
with targeted deletions in key inflammasome mole-
cules with mice on an L. major–susceptible BALB/c 
genetic background. We found L. major to activate 
the NLRP3 inflammasome in infected macrophages, 
which resulted in significant secretion of IL-1β and 
IL-18. Of note, Nlrp3–/–, Asc–/–, and Casp1–/– Casp11–/– 
mice were resistant to cutaneous L. major infection. 
Further analyses revealed that NLRP3 inflammasome–
induced IL-18 production promoted Th2 responses 
and inhibited Th1-adaptive immunity. IL-18–mediated 
skewing of adaptive immune responses was charac-
terized by reduced IFN-γ secretion by activated T 
cells and increased production of IL-4, a cytokine that 
exacerbates leishmaniasis pathology. Concurrently, 
neutralization of IL-18 reduced IL-4 production and 
inhibited L. major–induced disease pathogenesis in 
BALB/c mice (Figure 7).
Figure 5. NLRP3 inflammasome negatively regulates T cell– 
mediated IFN-γ production. WT (n = 18), Nlrp3–/– (n = 8), 
Asc–/– (n = 12), and Casp1–/– Casp11–/– (n = 9) mice were infected 
with 106 L. major promastigotes. Infected mice were eutha-
nized 28 days later, and draining popliteal lymph nodes were 
harvested. Single-cell suspensions of popliteal lymph node 
cells were stimulated with anti-CD3 and anti-CD28 antibodies 
for 4 hours in the presence of monesin. T cells and cytokine 
production were evaluated by flow cytometry. Representa-
tive flow plots of CD4+ (A) and CD8+ T cells (E) that produced 
IFN-γ. Cumulative bar scatter plots represent the frequen-
cies of CD4+ (B) and CD8+ T cells (F) that produced IFN-γ. 
Representative flow plot (C) and scatter plot (D) show the 
mean fluorescence intensity (MFI) of IFN-γ produced by CD4+ 
T cells. Representative flow plot (G) and scatter plot (H) show 
the MFI of IFN-γ produced by CD8+ T cells. Dunnett’s multiple 
comparisons test was used to evaluate significance between 
groups. Data represent the mean ± SEM. *P < 0.05;  
**P < 0.01; ***P < 0.001; ****P < 0.0001.
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The role of inflammasomes in Leishmania species infection is 
largely unclear. A recent report suggested that the NLRP3 inflam-
masome confers protection against Leishmania amazonensis 
(L. amazonensis) infection in resistant C57BL/6 mice (37). Similar 
to our results presented here, the cited report showed that Leishma-
nia species induces NLRP3 inflammasome activation and signifi-
cant IL-1β production from infected macrophages (37). This report 
further proposed that NLRP3 inflammasome deficiency increases 
susceptibility to L. amazonensis infection on a resistant C57BL/6 
background (37). In contrast, we demonstrate here that defec-
tive NLRP3 inflammasome activation renders mice on a suscep-
tible BALB/c genetic background resistant to L. major infection. 
Differences in results can be due to the use of different Leish-
mania species and/or the genetic background of inflammasome- 
Figure 6. IL-18 promotes Th2 responses during T cell activation in BALB/c mice. Single-cell suspensions of splenocytes from WT BALB/c mice were 
stimulated for 72 hours with anti-CD3 Ab in the presence of IL-1β and IL-18. IFN-γ (A) and IL-4 (B) cytokine levels in the supernatants were determined by 
ELISA. (C) WT BALB/c splenocytes were stimulated for 72 hours with anti-CD3 in the presence of IL-18 and IL-18BP, and IL-4 levels in the supernatants were 
determined by ELISA. (D–F) WT BALB/c mice were treated with PBS (n = 10) or IL-18BP (n = 10) on days –1, 0, 1, 3, 7, and 14. Mice were infected with 106  
L. major promastigotes, and footpad swelling was monitored on days 14 and 21 (D and E). (F) IL-4 cytokine levels in the footpads of infected mice were 
determined on day 21 after infection. (G and H) Single-cell suspensions of splenocytes from WT BALB/c mice were stimulated for 48 hours with anti-CD3 
Ab in the presence of IL-1β and IL-18, and expression of GATA3 was determined by flow cytometry. (G) Representative histogram plots of GATA3 expression. 
(H) MFI of GATA3 in CD4+ T cells. Data in A–C are presented as duplicates from 3 to 4 WT mice and are representative of at least 5 independent experi-
ments. Data in G and H are presented as duplicates from 2 WT mice and are representative of 2 independent experiments. Data represent the mean ± 
SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 by Mann-Whitney U test.
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response, depending on the cytokine milieu and genetic back-
ground of the host (43, 44). Thus, future studies looking at more 
in-depth, side-by-side analyses of Leishmania species infection 
in different genetic backgrounds are critically needed to discern 
the discrepancies between the various studies. Furthermore, 
our observation that IL-17 is significantly reduced in inflam-
masome-deficient mice during L. major infection warrants fur-
ther investigation. Given the role for IL-17 in potentiating leish-
maniasis (24), it is quite possible that both IL-17 and IL-4 are 
playing a synergistic role in disease progression. Future studies 
will elucidate the contribution of IL-1β and IL-18 in promoting 
IL-17 responses during L. major infection in mice. Nonetheless, 
our studies clearly show that in a susceptible BALB/c host, IL-18 
promotes a Th2-biased response, as determined by increased 
IL-4 production and reduced IFN-γ response. Given that IL-18 
was first discovered as an IFN-γ–inducing factor (45–47), we 
believe our studies uncover a novel role for IL-18 in certain set-
tings, in which IL-18 promotes Th2 responses.
In conclusion, we demonstrate that defective NLRP3 inflam-
masome activation increases resistance to L. major infection in 
a susceptible BALB/c genetic background. The increased resis-
tance in NLRP3 inflammasome–deficient mice is associated 
with reduced production of the hallmark Th2 cytokines IL-4 and 
IL-5, concomitant with increased production of the Th1-asso-
ciated cytokine IFN-γ. We further show that IL-18 is responsible 
for biasing Th1- and Th2-adaptive immune responses during 
deficient mice. In agreement, the NLRP3 inflammasome provides 
protection against L. amazonensis, but not L. major, in C57BL/6 
mice (37). Indeed, C57BL/6 and BALB/c mice are known to mount 
different immune responses to Leishmania species infection (7, 
38–40). C57BL/6 mice are relatively resistant, while BALB/c mice 
are highly susceptible to Leishmania species infection. These dif-
ferences highlight the need to closely evaluate immune responses 
during Leishmania species infections, since the responses can 
vary dramatically based on the genetic background of the host. 
Furthermore, Leishmania species themselves vary in the immune 
responses that they induce in the course of disease pathogenesis 
(34). For instance, Leishmania donovani (L. donovani) causes a 
highly lethal visceral infection, whereas L. major and L. amazonen-
sis trigger less severe, localized cutaneous infections (34).
IL-1β and IL-18 are inflammasome-dependent cytokines 
that contribute critically to immune responses during infections 
and autoimmune diseases. Our study shows that both IL-1β and 
IL-18 are produced during L. major infection in vitro and in vivo. 
Interestingly, our studies suggest IL-18 to be a central cytokine 
that modulates T cell responses during L. major infection. How-
ever, the role for IL-18 during Leishmania species infection is 
less clear in the literature. While some studies show a positive 
role for IL-18 in promoting Th1 responses and resistance dur-
ing Leishmania species infection (41), other studies have shown 
that IL-18 might enhance Th2-biased responses and promote 
susceptibility (42). Indeed, IL-18 can induce either a Th1 or Th2 
Figure 7. Model for L. major–induced NLPR3 inflammasome activation and IL-18–induced skewing of T cell responses. L. major infection of BALB/c 
mice activates NLRP3 inflammasomes and production of IL-1β and IL-18. IL-18 promotes a Th2-biased adaptive immune response and enhances IL-4 
production by CD4+ T cells.
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analyzed for the indicated cytokine and chemokine (Figures 3 and 4). 
For in vitro experiments, cell supernatants were collected at the end of 
the experiment and analyzed for the indicated cytokines and chemo-
kine. Concentrations of cytokines and chemokines were determined 
by multiplex ELISA for KC, IL-6, and TNF-α (EMD Millipore) and by 
classical ELISA for IL-1β (eBioscience) and IL-18 (MBL International).
In vitro restimulation and flow cytometry. Draining popliteal 
lymph nodes were harvested from mice, and single-cell suspen-
sions were made. Cells were then stimulated with anti-CD3 and 
anti-CD28 for 4 hours in the presence of monesin. The lymph node 
cells were then stained with CD4, CD8, IFN-γ, and TNF-α antibodies 
(eBioscience) and analyzed using the LSR-II flow cytometer (BD Bio-
sciences) and FlowJo software.
In vitro stimulation of splenocytes. Spleens were harvested from 
naive BALB/c mice, and a single-cell suspension was made. Red 
blood cells were lysed using ammonium-chloride-potassium lysis 
buffer. Splenocytes were counted and plated at 2 × 105 cells in a vol-
ume of 200 μl in 96-well round-bottomed plates. These splenocytes 
were stimulated with 1 μg/ml anti-CD3 in the presence or absence of 
IL-1β (10 ng/ml) and IL-18 (10 ng/ml). In some experiments, IL-18BP 
(1 μg/ml) was added to neutralize the effects of IL-18. Splenocytes 
were stimulated for 72 hours, and supernatants were collected and 
analyzed by ELISA for IL-4 and IFN-γ. For experiments involving 
transcription factors, splenocytes were stained with CD4 (eBiosci-
ence), GATA3 (BioLegend), and cMAF (eBioscience) and analyzed 
by flow cytometry.
IL-18 neutralization. To neutralize IL-18 in vivo, mice were admin-
istered 2 μg IL-18BP (RKQ9Z0M9; Reprokine) i.p. on day –1, day 0, 
day 1, day 3, day 7, and once a week thereafter.
Statistics. GraphPad Prism 5.0 software was used for data analysis. 
Data are represented as the mean ± SEM. Statistical significance was 
determined by the Mann-Whitney U test for comparison of 2 groups 
for in vitro and in vivo analysis and by Dunnett’s multiple comparisons 
test for comparison of multiple groups in vivo. A P value of less than 
0.05 was considered statistically significant.
Study approval. Animal studies were conducted under protocols 
approved by the IACUC of St. Jude Children’s Research Hospital.
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L. major infection. Furthermore, our data suggest that IL-18 
promotes IL-4 production, while limiting IFN-γ production by 
activated T cells, further expanding the mechanisms by which 
IL-18 modulates adaptive immune responses. Mechanistically, 
IL-18 induces greater expression of GATA3 and cMAF by acti-
vated CD4+ T cells to influence Th1 and Th2 biasing. Finally, we 
proved that the IL-18BP treatment that neutralized IL-18 protects 
BALB/c mice from L. major–induced footpad pathogenesis. 
Together, our results not only establish a detrimental role for the 
NLRP3 inflammasome during L. major infection, but also expose 
IL-18 as a potential therapeutic target in leishmaniasis.
Methods
Mice. Nlrp3–/– (14), Asc–/– (48), and Casp1–/– Casp11–/– (49) mice, all 
described previously (17), were backcrossed with BALB/c mice for 
more than 10 generations and maintained in our colony. The BALB/c 
WT mice were bred at St. Jude Children’s Research Hospital.
L. major infection. The L. major strain WHOM/IR/-173 was grown 
in vitro in complete M199 media supplemented with 5% HEPES, 10% 
FBS, and 1% penicillin-streptomycin at 27°C. Metacyclic promastig-
otes of L. major were purified using Lectin Agarose (Sigma-Aldrich) 
as previously described (50). Mice were infected with 106 L. major 
promastigotes per footpad in a volume of 50 μl. Footpad measure-
ments were taken weekly. Footpad sections were also analyzed for 
inflammation and necrosis by H&E staining. L. major MOI in the foot-
pads were determined by directly staining the footpad sections using 
Giemsa stain. For quantification of L. major promastigotes, footpads 
were homogenized, and serial limiting dilutions of the homogenates 
were plated in 96-well flat-bottomed plates in complete M199 media. 
Five to 6 days after culture, each well was analyzed under a micro-
scope for the presence or absence of L. major to determine the titers. 
For in vitro experiments, BMDMs were infected with 10, 20, or 50 
MOI of L. major for 48 hours.
Macrophage differentiation and stimulation. BMDMs were pre-
pared as described previously (17). Briefly, BM cells were grown in 
L cell–conditioned Iscove’s modified Dulbecco’s medium (IMDM) 
supplemented with 10% FBS, 1% nonessential amino acid, and 1% 
penicillin-streptomycin for 5 days to differentiate into macrophages. 
BMDMs were counted and seeded at 106 cells per well in 12-well cell 
culture plates on day 5. The next day, BMDMs were primed with LPS 
(500 ng/ml) for 4 hours, followed by infection with L. major for the 
next 48 hours. In other experiments, BMDMs were infected with 
the indicated MOI of L. major. One hour later, L. major was washed 
with PBS, and the clearance of L. major was followed over time using 
Giemsa staining (48900; Sigma-Aldrich).
Western blot analysis. Samples for immunoblotting were pre-
pared from footpad lysates made in radioimmunoprecipitation assay 
(RIPA) buffer supplemented with protease inhibitors. Samples were 
denatured in loading buffer containing SDS and 100 mM DTT and 
boiled for 5 minutes. SDS-PAGE–separated proteins were transferred 
to PVDF membranes and immunoblotted with primary antibodies 
against caspase 1 (AG-20B-0042; Adipogen) and GAPDH (D16H11; 
Cell Signaling Technology), followed by secondary anti-mouse and 
anti-rabbit HRP antibodies (Jackson ImmunoResearch Laboratories), 
as previously described (14).
Cytokine analysis. Footpads were homogenized in 1 ml PBS supple-
mented with protease inhibitors. The footpad supernatants were then 
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